News
The Egon Naef Foundation awards its 2023 prize to PD Dr Marco Alves
The Egon Naef Foundation for in vitro research has presented its 2023 prize to PD Dr Marco Alves of the IVI and the University of Bern. The researcher and his team have developed an in vitro model that demonstrates the infection of the human placenta by SARS-CoV-2.
Avian influenza
Application for approval of a vaccination of zoo birds against avian influenza (H5N1). The aim of the project is to protect endangered wild bird species living in zoos and safeguard their wellbeing.
Releases
Java script is required to display press releases. If you are unable or unwilling to activate Java script you may use the link below to access the Federal Administration News Portal, where you can read the announcements.
In focus
Improved COVID-19 vector vaccine candidate
In a recent publication, scientists at the Institute of Virology and Immunology (IVI) and the University of Bern report on a Vesicular Stomatitis Virus (VSV)-vectored COVID-19 vaccine candidate.
Rabies
Rabies in Switzerland: a daily battle. If a case of rabies is suspected, prompt action is vital to protect potentially exposed humans against this deadly zoonosis.
Blog - Young researchers from the IVI
Emilia Radulovic : “The results of my thesis on African swine fever are of major importance for the future development of live attenuated vaccines”.
Transfer of immunological veterinary medicinal products to Swissmedic
On 1 January 2023, responsibility for the authorisation, variation, batch release, market surveillance and licences for importing individual batches of immunological veterinary medicinal products was transferred from the Institute of Virology and Immunology (IVI) to Swissmedic.
In cooperation with Vetsuisse Faculty
www.ivi.unibe.ch